DeepMind

By Martin CoulterLONDON (Reuters) – Google (NASDAQ:) Deepmind has unveiled the third major version of its “AlphaFold” artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the company made a significant advance in molecular biology by using AI to successfully predict the behaviour…